STAT
We’ve assigned a rating of high factuality to STAT. You can read more about how we’ve determined STAT’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Does STAT lean left or right?
Learn more about Media Bias Ratings.
Top STAT News
Business · BentonvilleRetail giant Walmart on Tuesday become the latest major player in the drug industry to announce a plan to settle lawsuits filed by state and local governments over the toll of powerful prescription opioids sold at its pharmacies with state and local governments across the U.S.See the Story
Walmart to Pay $3.1 Billion to Settle Opioid Lawsuits
72% Center coverage: 185 sources
Europe · WashingtonThe World Health Organization is planning to rename monkeypox. The decision could be announced as early as Wednesday. It comes in response to growing pressure from senior Biden officials, who privately urged WHO leaders to change the name, Politico reported. It is an effort to destigmatize the virus that gained a foothold in the United States.See the Story
WHO plans to rename monkeypox to 'MPOX'
56% Center coverage: 131 sources
Diabetes · WashingtonThe world's first treatment which can delay the development of Type 1 diabetes has been licensed in the US.
See the Story
US regulator approves teplizumab which can delay the onset of Type 1 diabetes
74% Center coverage: 53 sources
Latest News Stories
MedicareThe provision is known as skinny labeling, which refers to a move by a company that seeks regulatory approval to market a generic or biosimilar medicine. By doing so, the company seeks to avoid lawsuits in which the brand-name manufacturer could claim patent infringement. Medicare saved $1.5 billion from 2015 to 2020, or nearly 5% of the $30.2 billion spent by the health care program.See the Story
'Skinny labels' on biosimilar medicines saved Medicare $1.5 billion over a recent five-year period
100% Center coverage: 1 sources
MerckFrazier, who is retiring as chairman of Merck on Dec. 1, joined STAT to reflect and to look toward the future. He talked about the role of the CEO, both in business and politics. He also spoke out on the problems of economic inequality and racial disparities in America.See the Story
Former Merck CEO: Democracy and the drug industry are both in danger
100% Center coverage: 1 sources
Health CareHealth systems need to reduce administrative harm to their workforces just as they work to prevent clinical injuries to their patients.See the Story
Minimizing administrative harm: a key step to improving health care
100% Center coverage: 1 sources
Lessons from a thriving physical therapist to a younger self just learning about multiple sclerosis
100% Center coverage: 1 sources
Europe · New YorkU.S. drugmaker Pfizer Inc (PFE.N) and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.See the Story
Pfizer, BioNTech start COVID-flu combination vaccine study
55% Center coverage: 31 sources
Abortion · WashingtonThe largest increases in medication abortion requests came from states with the most severe restrictions. The authors found no statistically significant changes in the reasons the abortion pills were requested in states with no planned changes to abortion laws. To get the medication, patients fill out online forms that are reviewed by a medical team, which sends prescriptions to pharmacies.See the Story
Online requests for abortion pills spiked after Roe was reversed: study
58% Center coverage: 12 sources
Business · New YorkFDA advisory committee will take up the issue of whether pulse oximeters need to be regulated differently. Research shows the devices are less accurate in people with darker skin. For decades, this knowledge remained largely out of sight and was not acted on by manufacturers. Five U.S. senators and a number of physicians think is overdue.See the Story
FDA advisers meet on racial disparities in pulse oximeters
68% Center coverage: 43 sources
Vaccinations · New YorkPreliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close. New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.See the Story
Pfizer says RSV vaccine is effective at preventing severe illness in babies
67% Center coverage: 85 sources
